NCT01635088View on ClinicalTrials.gov

Onset and Duration of Mometasone by Oscillometry and Spirometry

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Conditions
Asthma
Interventions
DRUG

Mometasone furoate 220

dry powder inhaler QD for 28-43 days

DEVICE

KoKo Spirometry

DRUG

Mometasone furoate 440

dry powder inhaler QD for 28-43 days

DEVICE

Oscillometry

Trial Locations (1)

90025

California Allergy and Asthma Medical Group, Inc., Los Angeles

All Listed Sponsors
lead

California Allergy and Asthma Medical Group, Inc.

OTHER

NCT01635088 - Onset and Duration of Mometasone by Oscillometry and Spirometry | Biotech Hunter | Biotech Hunter